ARTICLE | Company News
Durect, NeuroSystec Corp. deal
June 28, 2004 7:00 AM UTC
DRRX granted NeuroSystec exclusive worldwide rights to develop and market treatments for inner ear disorders using DRRX's drug delivery technologies. DRRX received an upfront fee and is eligible for m...